NAVAMEDIC ASA: årsregnskap 2021 vs 2020
Grew 47% on revenue, stronger earnings, cash halved-plus
registry 2022-08-30; journal 2022 901772
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for NAVAMEDIC ASA. Revenue 30.79m NOK → 45.26m NOK (+47.0%). Net result -17.28m NOK → -3.28m NOK. Equity 128.23m NOK → 145.7k NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded; cash fell.
Also worth watching: thin equity buffer; paid-in equity reduced; payroll increased. All figures are taken from the published annual accounts for NAVAMEDIC ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 30.79m NOK to 45.26m NOK (+47.0% YoY). Calculated
-
↑
Operating result improved
Operating result -8.82m NOK → -6.77m NOK (op. margin -28.7% → -15.0%). Calculated
-
↑
Net result improved
Net result -17.28m NOK → -3.28m NOK (net margin -56.1% → -7.3%). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 128.23m NOK → 145.7k NOK (equity ratio 58.7% → 0.1%). Calculated
-
↓
Cash fell
Bank deposits 5.57m NOK → 2.77m NOK (-50.3% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 0.1% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 158.93m NOK → 177.9k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Payroll increased
Salary cost 18.89m NOK → 30.73m NOK (61% → 68% of revenue). Calculated
-
·
Book investments changed
Investment / intangible book value 164.97m NOK → 129.61m NOK. Reported fact